New hope for aggressive lung cancer: can immunotherapy boost standard treatment?
NCT ID NCT04602533
Summary
This study is testing if adding a drug called durvalumab (an immunotherapy) to the standard treatment of chemotherapy and radiation helps people with limited-stage small cell lung cancer live longer without their cancer getting worse. About 105 participants will be randomly assigned to receive either the standard treatment alone or the standard treatment plus durvalumab, followed by ongoing durvalumab maintenance therapy. The main goal is to see if the combination treatment better controls the disease over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER LIMITED STAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asklepios Fachkliniken Muenchen Gauting
München Gauting, Bavaria, 82131, Germany
-
Asklepios Klinikum Hamburg
Hamburg, 21075, Germany
-
Helios Kliniken Erfurt
Erfurt, Thuringia, 99089, Germany
-
Johannes Wesling Klinikum Minden
Minden, North Rhine-Westphalia, 32429, Germany
-
KEM GmbH
Essen, North Rhine-Westphalia, 45136, Germany
-
Klinikum Ernst von Bergmann
Potsdam, Brandenburg, 14467, Germany
-
Klinikum Kassel GmbH-Klinik für Onkologie und Hämatologie
Kassel, Hesse, 34125, Germany
-
Klinikverbund Allgäu gGmbH
Immenstadt im Allgäu, Bavaria, 87509, Germany
-
Lungenklinik Hemer
Hemer, North Rhine-Westphalia, 58675, Germany
-
Lungenklinik Köln-Merheim
Cologne, North Rhine-Westphalia, 51109, Germany
-
Sana-Klinikum Offenbach
Offenbach, Hesse, 63069, Germany
-
Universitätsklinikum Aachen
Aachen, North Rhine-Westphalia, 52074, Germany
-
Universitätsklinikum Essen
Essen, North Rhine-Westphalia, 45147, Germany
-
Universitätsklinikum Gießen Marburg
Giessen, Hesse, 35392, Germany
-
Universitätsmedizin Rostock
Rostock, Mecklenburg-Vorpommern, 18059, Germany
Conditions
Explore the condition pages connected to this study.